摘要:
An apparatus for insertion, positioning and removal of an in-ear-canal hearing aid, comprising a resilient handle, an elongated support member configured to fit into an ear canal, the support member having a first end that is configured to engage the handle and a second end that includes magnetic engagement means configured to removably engage an in-ear-canal hearing aid, and an ear canal ingression stop that is configured to limit travel of the support member and, thereby, the in-ear-canal hearing aid when engaged thereto in the ear canal.
摘要:
The invention provides systems and methods for providing hearing aid. An open ear canal hearing aid may be provided in accordance with an embodiment of the invention. The hearing aid may include a part that contains electronic components, a passive amplifier, and a securing mechanism. The securing mechanism may include bristles or balloons. The securing mechanism may have various configurations and be adjustable.
摘要:
Systems for characterizing tissue comprise: a tissue probe comprising a plurality of probe electrodes; a signal generator, a controller, and a user interface. The signal generator is in communication with the probe electrodes for delivering a drive signal to at least one probe electrode. The controller receives a recorded signal from one or more probe electrodes, the recorded signal resulting from delivery of the drive signal through tissue proximate the plurality of probe electrodes. The controller is configured to determine patient-to-patient differences when the tissue probe is proximate a known type of patient tissue and/or bodily fluid, and it produces tissue characterization information based on the recorded signal and the patient-to-patient differences. The user interface provides the tissue characterization information to an operator of the system. Methods of characterizing tissue are also provided.
摘要:
The invention provides modified sodium iodide symporter (NIS) proteins, and polynucleotides encoding modified NIS proteins. The modified NIS proteins have a net electrostatic charge more positive than that of corresponding wild-type NIS proteins. Expression of a modified NIS protein in a cell results in higher intracellular concentrations of NIS substrates as compared to equivalent expression of the corresponding wild-type NIS protein in a cell. The invention also provides methods for imaging cells or for therapy of cancer cells, using the modified NIS proteins to facilitate transport of NIS substrates into cells in the body of an individual. Uptake of NIS substrates suitable for either imaging or that have cytotoxic activity, into the cells of the individual that express modified NIS protein facilitate detection of the substrate (for imaging) or killing of the cancer cells (for therapy).